CLINICAL_TRIALS
trial_result
· 2018-12-11
Clinical Trial Update: Study of Safety, Tolerability and Effectiveness of A-101 in Subjects With Seborrheic Keratosis [Phase 1, Phase 2]
Summary
Clinical trial updates safety and tolerability of A-101 in seborrheic keratosis across Phase 1 and Phase 2; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Aclaris Therapeutics, Inc. | Conditions: Seborrheic Keratosis (SK) | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-12-11